Multisystem Inflammatory Syndrome after Ad26.COV2.S vaccination
Background: The multisystem inflammatory syndrome (MIS) is a rare and sometime life-threatening post-infectious complication of coronavirus disease 2019 (Covid-19) in children and adults. To date, only a very few reports have associated such systemic reaction with SARS-CoV-2 vaccination. Case report...
Main Authors: | Carlo Bova, Ernesto Vigna, Massimo Gentile |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-01-01
|
Series: | IDCases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214250922000397 |
Similar Items
-
Multisystem Inflammatory Syndrome in Children
by: Ravinder K Gupta, et al.
Published: (2021-06-01) -
Multisystem inflammatory syndrome and lymphohistiocytic myocarditis after Covid‐19 vaccine in a middle‐aged woman
by: Kosuke Kobayashi, et al.
Published: (2023-04-01) -
Multisystem inflammatory syndrome in adults - In COVID-19
by: Vasantha Kamath, et al.
Published: (2023-01-01) -
Approaches to SARS-CoV-2 and other vaccinations in children with a history of multisystem inflammatory syndrome (MIS-C): An international survey
by: Francesca Minoia, et al.
Published: (2022-11-01) -
MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN: DIAGNOSTIC MARKERS AND FEATURES OF PHARMACOTHERAPY
by: M.V. Кhaitovych, et al.
Published: (2021-03-01)